CFTR Folding Consortium: Methods Available for Studies of CFTR Folding and Correction

Methods in Molecular Biology

Volumn 742, Issue , 2011, Pages 335-353

  Peters, Kathryn W ^a   Okiyoneda, Tsukasa ^b   Balch, William E ^c   Braakman, Ineke ^d   Brodsky, Jeffrey L ^e   Guggino, William B ^f   Penland, Christopher M ^g   Pollard, Harvey B ^h   Sorscher, Eric J ⁱ   Skach, William R ^j   Thomas, Philip J ^k   Lukacs, Gergely L ^b   Frizzell, Raymond A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g CYSTIC FIBROSIS FOUNDATION   (United States)

^h UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

antibody generation; cell surface protein detection; protein degradation; Protein folding; research consortium; www.cftrfolding.org

Indexed keywords

ANTIBODY; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CYSTIC FIBROSIS; ECONOMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FINANCIAL MANAGEMENT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; MUTATION; NON PROFIT ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOUNDATIONS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INDICATORS AND REAGENTS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; PROTEIN FOLDING; RESEARCH SUPPORT AS TOPIC;

EID: 80052541318     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-120-8_20     Document Type: Chapter

References (27)

1. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827–834.
2. Zhang, F., Kartner, N., and Lukacs, G. L. (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat Struct Biol 5, 180–183.
3. Du, K., Sharma, M., and Lukacs, G. L. (2005) The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12, 17–25.
4. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761–764.
5. Welch, W. J. (2004) Role of quality control pathways in human diseases involving protein misfolding. Semin Cell Dev Biol 15, 31–38.
6. Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803–815.
7. Zhang, Y., Nijbroek, G., Sullivan, M. L., McCracken, A. A., Watkins, S. C., Michaelis, S., et al. (2001) Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast. MolBiolCell12, 1303–1314.
8. Sun, F., Mi, Z., Condliffe, S. B., Bertrand, C. A., Gong, X., Lu, X., et al. (2008) Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. FASEB J 22, 3255–3263.
9. DeCarvalho, A. C., Gansheroff, L. J., and Teem, J. L. (2002) Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta F508. J Biol Chem 277, 35896–35905.
10. Teem, J. L., Carson, M. R., and Welsh, M. J. (1996) Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing. Receptors Channels 4, 63–72.
11. Chang, X. B., Cui, L., Hou, Y. X., Jensen, T. J., Aleksandrov, A. A., Mengos, A., et al. (1999) Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell 4, 137–142.
12. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J., et al. (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115, 2564–2571.
13. Van Goor, F., Straley, K. S., Cao, D., Gonzalez, J., Hadida, S., Hazlewood, A., et al. (2006) Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol 290, L1117–L1130.
14. Pyle, L. C., Balch, W. E., Lukacs, G., Braakman, I., Guggino, W. B., Thomas, P. J., et al. (2010) Developing a cellular road map for correctors of protein misfolding: a consortium approach. Nat Rev Drug Disc. (submitted).
15. Lukacs, G. L., Segal, G., Kartner, N., Grinstein, S., and Zhang, F. (1997) Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 328 (Pt 2), 353–361.
16. Prince, L. S., Peter, K., Hatton, S. R., Zaliauskiene, L., Cotlin, L. F., Clancy, J. P., et al. (1999) Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal. JBiol Chem 274, 3602–3609.
17. Benharouga, M., Haardt, M., Kartner, N., and Lukacs, G. L. (2001) COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from postGolgi compartments. JCellBiol153, 957– 970.
18. Denning, G. M., Ostedgaard, L. S., Cheng, S. H., Smith, A. E., and Welsh, M. J. (1992) Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J Clin Invest 89, 339–349.
19. Denning, G. M., Ostedgaard, L. S., and Welsh, M. J. (1992) Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. JCellBiol118, 551–559.
20. Sharma, M., Pampinella, F., Nemes, C., Benharouga, M., So, J., Du, K., et al. (2004) Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. JCellBiol164, 923–933.
21. Glozman, R., Okiyoneda, T., Mulvihill, C. M., Rini, J. M., Barriere, H., and Lukacs, G. L. (2009) N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. JCell Biol 184, 847–862.
22. Barriere, H., Bagdany, M., Bossard, F., Okiyoneda, T., Wojewodka, G., Gruenert, D., et al. (2009) Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles. Mol Biol Cell 20, 3125–3141.
23. Robert, R., Carlile, G. W., Pavel, C., Liu, N., Anjos, S. M., Liao, J., et al. (2008) Structural analog of sildenafil identified as a novel corrector of the F508del CFTR trafficking defect. Mol Pharm 73, 478–489.
24. Carlile, G. W., Robert, R., Zhang, D., Teske, K. A., Luo, Y., Hanrahan, J. W., et al. (2007) Correctors of protein trafficking defects identified by a novel high-throughput screening assay. ChemBioChem 8, 1012–1020.
25. Voller, A., Bidwell, D., Rose, N. R., Friedman, H., and Fahey, J. L. (1986) Enzymelinked immunosorbent assay, in Manual of Clinical Laboratory Immunology, vol. 3. American Society of Microbiology, Washington, DC, pp. 99–109.
26. Harlow, E., and Lane, D. (1988) Immunoprecipitation, in Antibodies: A Practical Approach.
27. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073.